Welcome to our dedicated page for Essent Group news (Ticker: $ESNT), a resource for investors and traders seeking the latest updates and insights on Essent Group stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Essent Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Essent Group's position in the market.
Essent Group reported net income of $181.7 million or $1.70 per diluted share for the first quarter of 2024, up from $170.8 million or $1.59 per diluted share in the same period last year. The Board of Directors declared a quarterly cash dividend of $0.28 per common share payable on June 10, 2024. The company highlighted strong credit performance, investment income growth, and the successful integration of the title business. Essent also entered into a quota share reinsurance transaction and received positive ratings from major agencies.